Skip to main content
Premium Trial:

Request an Annual Quote

Celera, Gemini Team Up In Disease Gene Hunt

Premium

ROCKVILLE, Md.--Celera Genomics and Gemini Research a wholly owned subsidiary of Gemini Holdings, in Cambridge, UK, have formed a collaboration to discover genes and genetic polymorphisms associated with common, chronic, age-related diseases. The collaboration combines Gemini's clinical genetics approach with Celera's DNA sequence information and computational gene discovery capabilities. Gemini's unique method of gene function discovery involves linking genetic differences in a defined population to variations in some 1,500 clinically significant risk traits collected from large numbers of identical and nonidentical twin subjects. The research will focus on those genetic regions or loci that Gemini has previously identified as likely to have genes that influence defined risk traits and, hence, the ultimate manifestation of disease. Under the terms of the agreement, both parties will jointly nominate traits and loci for research into the underlying genetic associations. The two companies intend to commercialize the jointly-owned results of the collaboration by jointly licensing the rights to discoveries to third parties interested in development of gene-based therapeutics and diagnostic products. Both parties will share in the revenues received from licensing fees, milestone payments, and royalties arising from the collaboration.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.